Genentech Presents New Long-Term Data for Vabysmo in Wet AMD and PCV at Euretina Congress 2025 Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), has announced compelling new data from two important clinical studies evaluating Vabysmo®…
SCIEX Expands BioPhase 8800 Capabilities with Native Fluorescence Detection to Advance Protein-Based CE Assays At the 2025 CE Pharm conference, SCIEX, a global leader in life science analytical technologies, announced the launch of native fluorescence detection on its flagship BioPhase…
Octave Bioscience Secures $35.6 Million Series C Financing and $15.5 Million Loan to Accelerate Growth and Advance Precision Care in Neurology Octave Bioscience, Inc., a commercial-stage precision care company dedicated to transforming the management of neurodegenerative diseases, has announced a…
MEDIPAL Holdings and JCR Pharmaceuticals Expand Rare Disease Collaboration with Global Licensing and Japan Co-Development Agreement for JR-479, a Novel Investigational Therapy for GM2 Gangliosidosis In a significant advancement for patients and families affected by ultra-rare lysosomal storage disorders, MEDIPAL…
Neurotech Pharmaceuticals Strengthens Leadership with Appointment of Dr. Peter J. McDonnell to Board of Directors Neurotech Pharmaceuticals, Inc., a privately held biotechnology company pioneering transformative therapies for chronic eye diseases, today announced the appointment of Peter J. McDonnell, M.D., a…
CapVest to Acquire Majority Stake in STADA from Bain Capital and Cinven CapVest Partners LLP (“CapVest”), a global investment firm with a reputation for building essential businesses across healthcare, consumer, and services sectors, has announced that it has signed a…
Ostro Unveils Airmark to Transform Static Pharma Emails into Dynamic, Compliant Conversational AI Ostro, an AI-powered engagement platform already trusted by more than half of the top 20 global pharmaceutical companies, has announced the launch of Ostro Airmark—a first-of-its-kind solution…
DNAnexus Expands Leadership to Drive AI Innovation and Biopharma Growth DNAnexus, Inc., a leader in enterprise solutions for precision health data, has unveiled a series of strategic leadership appointments that underscore its commitment to advancing artificial intelligence (AI), data-driven healthcare,…
Merck Reinforces Global Commitment to Cardiovascular Research with New Data Presentations at ESC Congress 2025 in Madrid Merck (NYSE: MRK), known as MSD outside the United States and Canada, has announced that a wide range of new clinical trial results…
AAHI and Quratis Forge Strategic Partnership to Transform Global Vaccine Manufacturing and Expand Access to Lifesaving Immunizations In a landmark development for global health equity, the Access to Advanced Health Institute (AAHI) has announced a strategic partnership with Quratis, a…
SMSbiotech Advances to First-in-Human Phase 1 Clinical Trial for COPD with Innovative Stem Cell Therapy San Diego-based regenerative medicine company begins groundbreaking trial in Australia, aiming to restore lung function in millions of patients worldwide. SMSbiotech, a biotechnology company headquartered…
Strand Therapeutics Strengthens Leadership with Appointment of Dr. Jason J. Luke as Chief Medical Officer Strand Therapeutics, a biotechnology company pioneering programmable messenger RNA (mRNA) medicines, has announced the appointment of Jason J. Luke, MD, FACP, as its new Chief…
